Advertisement
Screener

CELCUITY INC. (CELC) Operating Lease Cost

CELCUITY INC. Operating Lease Cost

CELCUITY INC. (CELC) reported Operating Lease Cost of $213.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingLeaseCost · last filed 2026-03-26

  • CELCUITY INC. operating lease, cost for the quarter ending 2022-06-30 was $48.65K, a 11.25% increase year-over-year.
  • CELCUITY INC. operating lease, cost for the quarter ending 2022-03-31 was $48.56K, a 6.88% increase year-over-year.
  • CELCUITY INC. operating lease, cost for the quarter ending 2021-12-31 was $48.65K, a 7.08% increase year-over-year.
  • CELCUITY INC. operating lease, cost for the quarter ending 2021-09-30 was $47.58K, a 8.19% increase year-over-year.
  • CELCUITY INC. operating lease, cost for fiscal 2025 was $213.00K, a 0.00% change from fiscal 2024.
  • CELCUITY INC. operating lease, cost for fiscal 2024 was $213.00K, a 0.36% increase from fiscal 2023.
  • CELCUITY INC. operating lease, cost for fiscal 2023 was $212.24K, a 7.32% increase from fiscal 2022.
  • CELCUITY INC. operating lease, cost for fiscal 2022 was $197.77K, a 6.68% increase from fiscal 2021.
Period endOperating Lease, Cost 3 monthOperating Lease, Cost 6 monthOperating Lease, Cost 9 monthOperating Lease, Cost 12 monthOperating Lease, Cost 12 month as first filed
2025-12-31$213.00K
10-K · filed 2026-03-26
2024-12-31$213.00K
10-K · filed 2026-03-26
$213.10K
10-K · filed 2025-03-31
2023-12-31$212.24K
10-K · filed 2025-03-31
2022-12-31$197.77K
10-K · filed 2024-03-27
2022-06-30$48.65K
10-Q · filed 2022-08-12
$97.20K
10-Q · filed 2022-08-12
$145.85K
derived: sum of 3 quarters · filed 2023-03-23
$193.43K
derived: sum of 4 quarters · filed 2023-03-23
2022-03-31$48.56K
10-Q · filed 2022-05-16
$97.20K
derived: sum of 2 quarters · filed 2023-03-23
$144.78K
derived: sum of 3 quarters · filed 2023-03-23
$188.51K
derived: sum of 4 quarters · filed 2023-03-23
2021-12-31$48.65K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$96.22K
derived: sum of 2 quarters · filed 2023-03-23
$139.95K
derived: sum of 3 quarters · filed 2023-03-23
$185.38K
10-K · filed 2023-03-23
2021-09-30$47.58K
10-Q · filed 2021-11-09
$91.30K
derived: sum of 2 quarters · filed 2021-11-09
$136.73K
10-Q · filed 2021-11-09
$182.16K
derived: sum of 4 quarters · filed 2022-03-23
2021-06-30$43.73K
10-Q · filed 2021-08-11
$89.16K
10-Q · filed 2021-08-11
$134.59K
derived: sum of 3 quarters · filed 2022-03-23
$178.56K
derived: sum of 4 quarters · filed 2022-03-23
2021-03-31$45.43K
10-Q · filed 2021-05-10
$90.86K
derived: sum of 2 quarters · filed 2022-03-23
$134.83K
derived: sum of 3 quarters · filed 2022-03-23
$175.90K
derived: sum of 4 quarters · filed 2022-03-23
2020-12-31$45.43K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23
$89.40K
derived: sum of 2 quarters · filed 2022-03-23
$130.47K
derived: sum of 3 quarters · filed 2022-03-23
$171.53K
10-K · filed 2022-03-23
2020-09-30$43.97K
10-Q · filed 2020-11-09
$85.04K
derived: sum of 2 quarters · filed 2020-11-09
$126.10K
10-Q · filed 2020-11-09
$167.16K
derived: sum of 4 quarters · filed 2021-02-16
2020-06-30$41.06K
10-Q/A · filed 2020-08-11
$82.13K
10-Q/A · filed 2020-08-11
$123.19K
derived: sum of 3 quarters · filed 2021-02-16
$164.25K
derived: sum of 4 quarters · filed 2021-02-16
2020-03-31$41.06K
10-Q · filed 2020-05-07
$82.13K
derived: sum of 2 quarters · filed 2021-02-16
$123.19K
derived: sum of 3 quarters · filed 2021-02-16
$164.25K
derived: sum of 4 quarters · filed 2021-02-16
2019-12-31$41.06K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
$82.13K
derived: sum of 2 quarters · filed 2021-02-16
$123.19K
derived: sum of 3 quarters · filed 2021-02-16
$164.25K
10-K · filed 2021-02-16
2019-09-30$41.06K
10-Q · filed 2019-11-07
$82.13K
derived: sum of 2 quarters · filed 2019-11-07
$123.19K
10-Q · filed 2019-11-07
2019-06-30$41.06K
10-Q · filed 2019-08-08
$82.13K
10-Q · filed 2019-08-08
2019-03-31$41.06K
10-Q · filed 2019-05-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERACYTE, INC. (VCYT)United States$3.904B41.21
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B